TrialBioMed research international2014

An ANOCEF genomic and transcriptomic microarray study of the response to irinotecan and bevacizumab in recurrent glioblastomas.

Julien Laffaire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.